Beyond simply breaking fat down, AOD9604 has been studied for its ability to limit new fat cell formation, making it useful for researchers investigating both sides of the fat accumulation equation in cell and animal models
Cardiology Case Studies Dermatology Endocrinology ENT Fertility Gastroenterology General General-Medicine Gynecology Hematology Infectious-Diseases Medical News Neurology Oncology Ophthalmology Orthopedics Pediatrics Procedure Public-Health Pulmonology Radiology Second Opinion Urology Wellness Woman-and-child
AOD 9604 is a synthetic peptide fragment derived from human growth hormone, while retatrutide is an investigational triple incretin receptor agonist currently in Phase 3 trials
By inhibiting NNMT, 5-Amino-1MQ may support cellular NAD+ levels, which are critical for mitochondrial function, energy metabolism, and cellular health
Initially, a person may need B12 supplementation shots every other day for around 2 weeks or until symptoms improve
Jan 29, 2026 You have been researching AOD-9604 for weeks